Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis

Figure 1

Structure of network formed by interventions. The lines between treatment nodes indicate the direct comparisons made within randomized controlled trials. Numbers () near the line indicate “number of trials/number of participants” of the related comparisons.